News

WASHINGTON, D.C. – Today, Congressman Morgan Griffith (VA-09), Chairman of the Subcommittee on Health, led a hearing titled Policies to Protect Our Communities from Illicit Drug Threats . “I hear countless stories across my district of individuals taking illicit drugs and mixing them with drugs we discussed today, like xylazine and fentanyl,” said Chairman Griffith.   “While some of these bills may need further work, it is critical that we continue to look for ways to restrict access to lethal and dangerous substances in order to protect American lives, strengthen public safety, and prevent further harm to families and communities nationwide.” Watch the full hearing  here . Below are key excerpts from today’s hearing: Congressman John Joyce, M.D. (PA-13) on H.R. 1266, the  Combating Illicit Xylazine Act : “Under the leadership of President Trump, we have finally closed our Southern Border and made all Americans safer by that action. However, we all recognize there is more work to be done, and I am pleased to see many pieces of legislation that are being considered today that will do exactly that. First, xylazine, referred to as “tranq”, is now reported to be the most commonly mixed alternate drug being stored and transferred and mixed and sold with heroin, with fentanyl, with cocaine. When I talk to the coroners at home and I ask them which drug is most commonly being used in South Central Pennsylvania, they say, ‘I’ll tell you what it’s being mixed with, it’s being mixed with tranq.’ And then it’s a polymorphous mixture of drugs that come in with it. I’d like to really publicly express my strong support for H.R. 1266, The Combating Illicit Xylazine Act, led by Representatives Panetta and Pfluger, which would permanently schedule this substance while providing the necessary safe harbor for its continued legitimate veterinary use.” Congressman Neal Dunn, M.D. (FL-02) on H.R. 7184, the  PRESS Act :  “You know, in 2025, the CDC reported an estimated 72,000 deaths from overdose, so think about that for a minute; 72,000 peoples’ souls lost. You know, it highlights the brokenness of our system. I think we can fix this. I think the bills before us today represent some real, concrete solutions to address the crisis that has claimed more American lives than any war in modern history. Fentanyl alone accounts for an estimated 45,000 deaths in 2025, and that threat is not static; it’s evolving. It’s changing. As we’ve discussed today, it’s almost faster than our regulatory framework can track. And I’m aware that there’s many problems that cause this, but I want to focus on the sort of upstream sources right now. This is not just a domestic public health problem. This is a national security issue, and it has a return address. The Chinese Communist Party has subsidized and incentivized the chemical companies in our country to export fentanyl and all these other related precursors to produce synthetic opioids and whatnot that are illicitly sold in the United States. And I don’t think this is negligence. This is policy.” Congresswoman Mariannette Miller-Meeks (IA-01) on H.R. 1227, the Alternatives to Pain Act :  “Increasing access to opioid alternatives not only can reduce the cost of medical care but can also improve patient outcomes. One of my constituents from Iowa city, John Greenwood’s story, exemplifies this strategy. John is the Chief Strategy Officer of Goldfinch Health, an organization that launched the Billion Pill Pledge to help reduce the number of opioids left over after surgery by 1 billion. John trains health care professionals about optimal pain management, but this work is also personal to him because his son was born with a missing bone in his skull and has required 13 operations in five years. By utilizing only non-opioid therapeutics, his son was able to get through a seven-hour skull operation and recover with zero complaints about the pain while being treated at the University of Iowa Children’s Hospital. Because of his son’s recovery, which was smooth and comfortable, he was able to be discharged from the hospital four days early. This also saved the health care system and the family thousands of dollars in NICU costs alone. My bill, the Alternatives to Pain Act, is written to ensure more patients get this approach and reduce the risk of addiction from prescription opioids.”   ###

WASHINGTON, D.C. –  Congressman Morgan Griffith (VA-09), Chairman of the Subcommittee on Health, delivered the following opening statement at today’s hearing titled  Policies to Protect Our Communities from Illicit Drug Threats . Subcommittee Chairman Griffith’s opening statement as prepared for delivery: “In today’s hearing we will discuss fourteen bills aimed at protecting Americans from illicit drug threats. “Illicit drugs continue to pose a serious and evolving challenge to American safety and national security—fueling overdose deaths, increasing crime, and putting immense pressure on law enforcement and public health systems. “So far this Congress, we have gotten strong policies across the finish line to crack down on the illicit drugs crisis that we see across the country. However, there is still more to be done to protect our communities from these lethal substances. “This is an issue that affects particularly Virginia, and Appalachia, who have unfortunately been impacted by the opioid epidemic. “I hear countless stories across my district of individuals taking illicit drugs and mixing them with drugs we will be discussing today like xylazine and fentanyl. Many of these illicit drugs are coming from illegal pill presses often with ingredients coming from China. “Our local law enforcement have been on the front lines battling this crisis and this hearing will give us the opportunity to build on the work this subcommittee did in passing the HALT Fentanyl Act, led by myself and Mr. Latta, and the SUPPORT for Patients and Communities Reauthorization Act, led by Chairman Guthrie. The President signed both of these pieces of legislation into law last year. “We will examine H.R. 1266, the Combatting Illicit Xylazine Act, led by Representative Pfluger from Texas. This bill would classify Xylazine as Schedule III under the Controlled Substances Act, while also protecting its legitimate use in large animal veterinary medicine. “This is extremely important for my district because, according to the National Cattlemen’s Association, Virginia’s Ninth District is the largest cattle-producing Congressional district east of the Mississippi River. “H.R. 5630, an important data collection issue that is championed by Representative Houchin from Indiana, would require enhanced data collection and reporting for opioid use disorder diversion data as part of a State’s plans for their Substance Use Prevention, Treatment, and Recovery Services block grants. “H.R. 2004 Tyler’s Law is led by Representative Latta from Ohio. The bill would require the Department of Health and Human Services to complete a study on how frequently hospitals test for fentanyl in patients experiencing an overdose and then use its results to issue guidance on implementing fentanyl testing in emergency rooms. “Also introduced by Representative Latta is H.R. 7970, the Strengthening Tools to Outlaw Poisonous (STOP) Nitazenes Act, which would permanently schedule nitazenes as Schedule I controlled substances. “H.R. 8000, the End Needless Distribution (END) of 7-OH Act led by Representative Bilirakis from Florida would regulate synthetic versions of 7-OH as a Schedule I controlled substance. “Representative Hageman from Wyoming champions H.R. 5880, the Fight Illicit Pill Presses Act, which would add a serialization requirement for pill presses and punches. “H.R. 1227, the Alternatives to Prevent Addiction in the Nation (or PAIN) Act led by Representative Miller Meeks from Iowa and Representative Barragan from California, which I am a cosponsor of, would expand access for seniors to non-opioid pain management options in Medicare Part D. “H.R. 2715, the Destruction of Hazardous Imports Act introduced by Representatives Higgins and Carter from Louisiana, would grant the FDA authority to destroy any FDA-regulated products that pose a significant risk to U.S. public health at our ports. “We will also be discussing other bills that deal with addressing this illicit drug issue and while some of these bills may need further work, it is critical that we continue to look for ways to restrict access to lethal and dangerous substances in order to protect American lives, strengthen public safety, and prevent further harm to families and communities nationwide. “I   look forward to hearing from our witnesses before us and to the discussion.”

WASHINGTON, D.C.  – This week, the House Committee on Energy and Commerce is holding two Subcommittee Hearings and one Full Committee Markup. Read more below.  FULL COMMITTEE MARKUP: The Committee on Energy and Commerce will hold a markup of two bills to reauthorize FirstNet and modernize the emergency alert system.  DATE:  Wednesday, March 25, 2026   TIME:  10:15 AM ET  LOCATION:  2123 Rayburn House Office Building  SUBCOMMITTEE HEARING:  The Energy and Commerce Subcommittee on Communications and Technology is holding a hearing to review the 1996 Telecom Act.   DATE:  Thursday, March 26, 2026   TIME:  10:15 AM ET  LOCATION:  2123 Rayburn House Office Building  SUBCOMMITTEE HEARING:  The Energy and Commerce Subcommittee on Health is holding a hearing on how the Committee is cracking down on illicit drug threats in order to protect Americans families and keep communities safe.  DATE:  Thursday, March 26, 2026  TIME:  2:00 PM ET  LOCATION:  2123 Rayburn House Office Building  ###

WASHINGTON, D.C.  – Today, Congressman Brett Guthrie (KY-02), Chairman of the Committee on Energy and Commerce, Speaker Mike Johnson (LA-04), Majority Leader Steve Scalise (LA-01), Congressman Jim Jordan (OH-04), Chairman of the Committee on the Judiciary, and Congressman Brian Babin (TX-36), Chairman of the Committee on Science, Space, and Technology, issued the following statement after the White House released a  federal AI framework . “AI has begun to demonstrate its potential to improve Americans’ lives. To ensure we continue to harness its potential and beat China in the global AI race, Congress must take action. Today, the Trump Administration took a critical step in releasing a framework that gives Congress a roadmap to pursue legislation that provides innovators with much-needed certainty, while protecting consumers and prioritizing kids’ online safety. House Republicans look forward to working across the aisle to enact a national framework that unleashes the full potential of AI, cements the U.S. as the global leader, and provides important protections for American families.” ###

WASHINGTON, D.C.  –   Today, Congressman Brett Guthrie (KY-02), Chairman of the House Committee on Energy and Commerce, and Congressman Morgan Griffith (VA-09), Chairman of the Subcommittee on Health, announced a hearing titled  Policies to Protect Our Communities from Illicit Drug Threats. “As new and emerging drug threats arise in communities across America, it’s vital this Committee continues to implement solutions that prevent illicit drugs from causing any more damage for American families,”  said Chairmen Guthrie and Griffith . “This hearing builds on critical pieces of legislation that President Trump signed into law last year, like the HALT Fentanyl Act and the SUPPORT for Patients and Communities Reauthorization Act. We will also discuss several additional bills that actively promote the safety of our constituents and crack down on the infiltration of lethal substances into our communities. We are grateful to our bill sponsors for championing these policies, because there is always more that can be done to combat the illicit drug crisis.” Subcommittee on Health legislative hearing titled  Policies to Protect Our Communities From Illicit Drug Threats . WHAT:  Subcommittee on Health legislative hearing on how the Committee is cracking down on illicit drug threats in order to protect Americans families and keep communities safe. DATE:  Thursday, March 26, 2026       TIME:  2:00 PM ET LOCATION:  2123 Rayburn House Office Building This hearing will focus on the following bills:  H.R. 1266 ,  Combatting Illicit Xylazine Act (Reps. Panetta and Pfluger) H.R. 5630 ,  To amend the Public Health Service Act to require additional information in State plans for Substance Use Prevention, Treatment, and Recovery Services block grants (Rep. Houchin) H.R. 5629 ,  To provide that the final rule of the Department of Health and Human Services titled “Medications for the Treatment of Opioid Use Disorder”, except for the portion of the final rule relating to accreditation of opioid treatment programs, shall have no force or effect. (Rep. Houchin) H.R. 2004 ,  Tyler’s Law (Reps. Lieu and Latta) H.R. 7970 ,  STOP Nitazenes Act (Rep. Latta) H.R. 8000 ,  END 7-OH Act (Rep. Bilirakis) H.R. 7184 ,  PRESS Act (Rep. McDowell) H.R. 8005 ,  Stop Pills That Kill Act (Rep. Evans) H.R. 5880 ,  Fight Illicit Pill Presses Act (Reps. Hageman and Stansbury) H.R. 1227 ,  Alternatives to Pain Act (Reps. Miller-Meeks and Barragan) H.R. 2715 ,  Destruction of Hazardous Imports Act (Reps. Higgins and Carter) H.R. 1561 ,  ALERT Communities Act (Reps. Crockett and Gooden) H.R. 7994 ,  HERO Act (Rep. Ruiz) H.R. 7407 ,  Prohibiting Tianeptine and Other Dangerous Products Act of 2026 (Rep. Pallone) This notice is at the direction of the Chairman. This hearing will be open to the public and press and will be livestreamed at  energycommerce.house.gov . If you have any questions about this hearing, please contact Annabelle Huffman with the Committee staff at  Annabelle.Huffman@mail.house.gov . If you have any press-related questions, please contact Katie West at  Katie.West@mail.house.gov . ###

WASHINGTON, D.C.  – Congressman Morgan Griffith (VA-09), Chairman of the Subcommittee on Health, delivered the following opening statement at today’s hearing titled  Lowering Health Care Costs for All Americans: An Examination of the U.S. Provider Landscape . Subcommittee Chairman Griffith’s opening statement as prepared for delivery: “Today we will discuss health care costs and patient access challenges by examining the health care provider landscape.   “This is the third hearing in the Committee’s health affordability series following hearings with health insurance executives back in January and stakeholders from the prescription drug supply chain last month.    “The United States provider landscape includes a wide range of entities and organizations that deliver services to patients.   “Hospitals and large health systems provide acute and specialized care. However, we have also seen these entities expand into outpatient service delivery.   “Independent physician practices and group practices deliver much of the primary and outpatient services that patients rely on every day.   “Although they are not before us in this hearing, I also want to recognize the critical role that federally qualified health centers, rural health clinics, and community hospitals play in our health system, especially in our most rural and underserved areas.   “It is no secret that across the country patients are faced with fewer choices about where they can receive care, as the provider market has consolidated dramatically.    “Hospitals are acquiring physician practices, systems are merging, and too often, patients have little options among providers.     “In many cases, the states that see the most consolidation have the largest rural populations—exacerbating access challenges, leaving communities strained, and contributing to overall unaffordability.   “On top of vertical integration limiting the viability of independent practices, the so-called Affordable Care Act has enabled the landscape to become even more narrow.   “In fact, because of the Affordable Care Act, any existing physician-owned hospital built before 2010 is prohibited from growing beyond the size it was when the bill became law. How does that make sense?   “As a result, many patients face limited provider options in their communities and may encounter higher prices with little insight into the cost of health services.   “At the same time, transparency amongst the health care provider system remains insufficient.   “Prices can vary widely for the same service depending on where care is delivered, and billing statements may include facility fees, multiple providers, and negotiated rates that are difficult for patients to understand.    “Additionally, programs such as the 340B Drug Pricing Program have become opaque and some hospitals have gone against the true intent of the program.    “The 340B Program was created with the intention of helping safety-net providers care for low-income and vulnerable patients; however, as hospitals and larger entities participate and expand affiliated contract pharmacies, visibility has become limited into how the program’s generated discounts are used and whether those savings are reaching patients.   “In many cases, the result of this system is that Americans are left navigating complex, and often expensive, medical bills—whether from a hospital visit or routine appointment—that they did not anticipate, cannot easily afford, and sometimes only learn about weeks or months after receiving care.   “When provider markets lack competition and transparency, prices can rise without patients having the information needed to make cost-conscious decisions.   “Today we will hear from different organizations that represent health care providers across a variety of settings, so that we can look for ways to try and make delivering and receiving care more affordable.    “We have the American Hospital Association in front of us who represents many types of hospitals and health care networks.   “We will also hear from the American Medical Association who represents physicians across the country.   “The American Academy of Family Physicians is here to give the perspective of family medicine practitioners.    “We also have the Purchaser Business Group on Health before us to provide insights into the relationship between private employers and public purchasers.   “We also have a neurosurgeon from the University of California San Francisco to give the perspective of specialty doctors and the care they provide to patients.    “Lastly, we have Barbara Merrill from the American Network of Community Options and Resources.   “These witnesses have unique insights into the factors that are currently leading to the high costs patients are facing when receiving care, and I am looking forward to the discussion.”   ###

WASHINGTON, D.C. – Today, Congressman Morgan Griffith (VA-09), Chairman of the Subcommittee on Health, led a hearing titled  Lowering Health Care Costs for All Americans: An Examination of the U.S. Provider Landscape . During the hearing, we heard members express their concerns with how hospital consolidation and lack of price transparency drive up costs for American patients.  “When provider markets lack competition and transparency, prices can rise without patients having the information needed to make cost-conscious decisions,” said Chairman Griffith.   “Today, we heard from different organizations that represent health care providers across a variety of settings, so that we can continue to look for solutions that make delivering and receiving care more affordable.”   Watch the full hearing  here . Below are key excerpts from today’s hearing: Congresswoman Mariannette Miller-Meeks (IA-01):  “ Today’s hearing is critically important because every policy discussion [involves] real patients—employers trying to provide health insurance, families trying to afford care, seniors managing chronic conditions, and providers working to keep their doors open in increasingly complex systems. Over the past decade or so, we’ve seen significant consolidation across the health care system—especially after the passage of the Unaffordable Care Act—and particularly among hospitals and large health systems. At the same time, Medicare physician reimbursement has declined by over 30 percent in inflation-adjusted dollars since 2001. If we continue on the current path, we’re not just cutting payments, we are cutting access. In rural Iowa, we don’t have an excess of providers. When one closes, patients have to drive hours for care. A 2 percent to 3 percent cut in Washington can mean the difference between staying open and shutting down in a small town.” Congressman Cliff Bentz (OR-02):  “It almost seems as though the [physician] shortage gives people an excuse to raise prices. Is that the truth?”  Dr. DiGiorgio:  “I agree.”  Congressman Bentz:  “We’ve heard that in other conversations with various groups. And by the way, the remarks about larger systems resulting in higher quality care at less cost, I have to beg to differ. At least in previous conversations, it appeared that there was a focus on those types of things, while ignoring the amount of money being made on the float by delaying care. I asked that question of UnitedHealthcare when they were here. It was discouraging to hear how many billions of dollars are being made on the float, I must say. And that appears to be something we should be focusing upon.” Congresswoman Erin Houchin (IN-09):  “This is the third hearing we’ve had on affordability. I think it may be the most consequential because the provider landscape is where these issues meet real patients. Doctor Aizuss, in your testimony, you note that practice costs rose roughly 63 percent over the same period that Medicare physician payments declined by roughly 33 percent, putting an increasing strain on independent practices and threatening patients’ access to care—particularly in rural parts of the country. From your perspective, how is this sustained gap affecting patients’ ability to access timely, quality care? What specific actions should Congress take to stabilize physician practices and prevent further disruptions?”  Dr. Aizuss:  “As I’ve noted, the decrease in real payment for Medicare services is accelerating independent physicians to close their offices or to sell their practices to private equity or to be employed by large systems. So, the access is definitely impacted by that. People in their own communities can’t access the private practice physician when they want to. And wait times are increasing significantly. The biggest solution, as I keep emphasizing, is having Medicare payment reform tied to the medical economic index with automatic inflationary updates—just like the other providers are receiving.” ###

WASHINGTON, D.C.  – This week, the House Committee on Energy and Commerce is holding four Subcommittee Hearings. Read more below.  SUBCOMMITTEE HEARING:  The Energy and Commerce Subcommittee on Energy is holding a hearing to discuss the lessons learned from Winter Storm Fern. DATE:  Tuesday, March 17, 2026   TIME:  10:00 AM ET  LOCATION:  2123 Rayburn House Office Building  SUBCOMMITTEE HEARING:  The Energy and Commerce Subcommittee on Oversight and Investigations is holding a hearing on what the Trump Administration is doing to proactively tackle Medicare and Medicaid fraud, as well as continuing conversations surrounding common fraud schemes and programs that are vulnerable to fraud. DATE:  Tuesday, March 17, 2026  TIME:  2:00 PM ET  LOCATION:  2123 Rayburn House Office Building  SUBCOMMITTEE HEARING:  The Energy and Commerce Subcommittee on Health is holding a hearing on the role that providers play in making health care more affordable for all Americans.   DATE:  Wednesday, March 18, 2026  TIME:  10:15 AM ET  LOCATION:  2123 Rayburn House Office Building   SUBCOMMITTEE HEARING:  The Energy and Commerce Subcommittee on Communications and Technology is holding a hearing on the World Radiocommunication Conference.   DATE:  Wednesday, March 18, 2026  TIME:  2:00 PM ET  LOCATION:  2123 Rayburn House Office Building  ###

WASHINGTON, D.C.  – Today, Congressman Brett Guthrie (KY-02), Chairman of the House Committee on Energy and Commerce, and Congressman Morgan Griffith (VA-09), Chairman of the Subcommittee on Health, announced a hearing titled Lowering Health Care Costs for All Americans: An Examination of the U.S. Provider Landscape.   “The third hearing in the Committee’s health care affordability series will examine the role that providers and hospitals play in shaping the cost of care for Americans,” said Chairman Guthrie.  “Hospitals, physicians, and health care practitioners play a vital role in delivering health care services to patients. This hearing will explore how payment policies, competition, transparency, and other incentives shape patient access and the cost of care. We look forward to hearing from the panelists on potential solutions as the Committee continues working to make health care more affordable for the American people.”   “From consolidation in the insurance marketplace to predatory practices in the pharmaceutical drug supply chain, the Health Subcommittee continues to examine all angles in our push to lower health care costs for American patients,” said Chairman Griffith. “Accordingly, our next hearing will address the role of hospital providers to better understand what can be done to make health care more affordable for all Americans.”   Subcommittee on Health hearing titled  Lowering Health Care Costs for All Americans: An Examination of the U.S. Provider Landscape .   WHAT:  Subcommittee on Health hearing on the role that providers play in making health care more affordable for all Americans.  DATE:  Wednesday, March 18, 2026   TIME:  10:15 AM ET  LOCATION:  2123 Rayburn House Office Building   This notice is at the direction of the Chairman. This hearing will be open to the public and press and will be livestreamed at  energycommerce.house.gov . If you have any questions about this hearing, please contact Annabelle Huffman with the Committee staff at  Annabelle.Huffman@mail.house.gov . If you have any press-related questions, please contact Katie West at  Katie.West@mail.house.gov .  ###